Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Welcure Drugs & Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]24.550.000.000.000.00
Other Operating Revenues0.000.000.000.110.13
Total Operating Revenues24.550.000.000.110.13
      
Other Income1.910.090.240.000.00
Total Revenue26.460.090.240.110.13
      
EXPENSES     
Purchase Of Stock-In Trade164.030.000.000.000.00
Changes In Inventories Of FG,WIP And Stock-In Trade-143.520.000.000.000.00
Employee Benefit Expenses0.280.090.040.010.01
Depreciation And Amortisation Expenses0.010.040.000.000.00
Other Expenses2.890.150.090.070.07
Total Expenses23.680.270.140.080.08
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2.78-0.170.100.020.06
      
Profit/Loss Before Tax2.78-0.170.100.020.06
      
Tax Expenses-Continued Operations     
Current Tax0.610.000.000.000.00
Total Tax Expenses0.610.000.000.000.00
Profit/Loss After Tax And Before ExtraOrdinary Items2.17-0.170.100.020.06
      
Profit/Loss From Continuing Operations2.17-0.170.100.020.06
      
Profit/Loss For The Period2.17-0.170.100.020.06
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)0.36-0.120.080.020.05
Diluted EPS (Rs.)0.36-0.120.080.020.05